Kyle Clifton

Kyle has 15 years of experience in the healthcare industry with significant expertise in commercial and market access strategies. Over this time, he has been increasingly responsible for leading the access planning and value development activities for pharmaceuticals across many therapeutic areas and orphan diseases. He has expertise in assessing healthcare policy, developing stakeholder-specific value messages, conducting market assessments and indication prioritizations, developing evidence-generation strategies, and assessing the price/value relationship.  He has delivered presentations to physician offices on payer management, reimbursement support, and financial assistance programs to increase on-therapy patient pull-through. Kyle earned masters degrees in business administration and health sector management from the W. P. Carey School of Business at Arizona State University, and a bachelor of arts in business administration with a minor in English from Rhodes College in Memphis, Tennessee. He also completed the Project Management Professional certification through the Project Management Institute.